Re: the sooner you start...

https://www.weyburnreview.com/news/local-news/comp-grad-leads-research-1.2261882


A subsequent, and much larger study run by Grohn and his team, had a surprising finding when they began using C60 purchased from a large chemical distributor. After the publication of the very first findings regarding C60 many individuals began self-administering C60 in the hope of treating various ailments.
These individuals are able to purchase C60 from distributors who state it is “not for human consumption” but also describe many positive qualities allowing the purchaser to assume those benefits would be found in themselves as well. While initial research with C60 showed a reduction in tumor growth, the study Grohn conducted using commercially available C60 found a massive increase in tumor growth.
Grohn set out to solve this mystery and in doing so developed a method to detect specific degradants of C60 which were previously undetected. Ultimately, Grohn discovered that C60-olive oil solutions are sensitive to light and that commercially available options show evidence of degradation due to light, which may cause them to become toxic. Research being conducted by Grohn now is studying the toxic nature of degraded C60. All of these findings are critical for both researchers using C60 and anyone choosing to consume it.
When C60 is prepared correctly and not exposed to light the positive effect on tumor growth remains. Without this finding any further research in to C60 could be severely retarded and a potential cure for this devastating disease left unexplored.
“We did not expect that the laboratory grade chemicals we purchased from a major distributor would be the cause for these problems. Recognizing this issue not only improves our research but will positively impact any other labs using C60,” Grohn said. Tweet